Eli Lilly: The Challenger with a Dual-Action Advantage Pharma giant Eli Lilly has shaken up the anti-obesity drug market with tirzepatide branded as MOUNJARO for diabetes and ZEPBOUND for obesity
"Many cases of OSA go undiagnosed and untreated, leaving millions at risk for serious health consequences," Patrik Jonsson, president of Lilly Cardiometabolic Health, said in a news release from the company
All statements reflect general wellness insights and affiliate-supported content that should not be interpreted as medical claims
How should I dispose of expired semaglutide
Never guess your dose or change your schedule without your healthcare provider call 403.452.5699 or book online
Symptoms include swelling of your face, lips, tongue, or throat, as well as a severe rash